Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
March 3, 2007
Open fields (unlike wheels) can be any shape but still miss the target
S Clare Stanford
Neuronal Signaling
|
January 9, 2023
Celebrating 125 years of the synapse: from Sherrington to the present day
S Clare Stanford
Journal of Psychopharmacology (Oxford, England)
|
March 12, 2008
ABPI/Bioscience Federation 'In vivo sciences in the UK: sustaining the supply of skills in the 21st century': fast-tracking a u-turn
S Clare Stanford
Journal of Psychopharmacology (Oxford, England)
|
August 26, 2025
Appraisal of the validity of preclinical investigations to predict the efficacy of psychedelic drugs as fast-acting antidepressants
S Clare Stanford
Journal of Psychopharmacology (Oxford, England)
|
March 3, 2007
The Open Field Test: reinventing the wheel
S Clare Stanford
BMJ (Clinical Research Ed.)
|
June 9, 2012
The NHS is right to fund homoeopathy
S Clare Stanford
Neuropharmacology
|
April 15, 2014
Psychostimulants, antidepressants and neurokinin-1 receptor antagonists ('motor disinhibitors') have overlapping, but distinct, effects on monoamine transmission: the involvement of L-type Ca2+ channels and implications for the treatment of ADHD
S Clare Stanford
Current Topics in Behavioral Neurosciences
|
May 23, 2022
Animal Models of ADHD?
S Clare Stanford
Alternatives to Laboratory Animals : ATLA
|
August 12, 2020
Some Reasons Why Preclinical Studies of Psychiatric Disorders Fail to Translate: What Can Be Rescued from the Misunderstanding and Misuse of Animal 'Models'?
S Clare Stanford
British Journal of Pharmacology
|
February 2, 2022
New developments in the prospects for GLP-1 therapy
Stefan Trapp, S Clare Stanford
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Journal of Psychopharmacology (Oxford, England)
|
March 3, 2007
Open fields (unlike wheels) can be any shape but still miss the target
S Clare Stanford
Neuronal Signaling
|
January 9, 2023
Celebrating 125 years of the synapse: from Sherrington to the present day
S Clare Stanford
Journal of Psychopharmacology (Oxford, England)
|
March 12, 2008
ABPI/Bioscience Federation 'In vivo sciences in the UK: sustaining the supply of skills in the 21st century': fast-tracking a u-turn
S Clare Stanford
Journal of Psychopharmacology (Oxford, England)
|
August 26, 2025
Appraisal of the validity of preclinical investigations to predict the efficacy of psychedelic drugs as fast-acting antidepressants
S Clare Stanford
Journal of Psychopharmacology (Oxford, England)
|
March 3, 2007
The Open Field Test: reinventing the wheel
S Clare Stanford
BMJ (Clinical Research Ed.)
|
June 9, 2012
The NHS is right to fund homoeopathy
S Clare Stanford
Neuropharmacology
|
April 15, 2014
Psychostimulants, antidepressants and neurokinin-1 receptor antagonists ('motor disinhibitors') have overlapping, but distinct, effects on monoamine transmission: the involvement of L-type Ca2+ channels and implications for the treatment of ADHD
S Clare Stanford
Current Topics in Behavioral Neurosciences
|
May 23, 2022
Animal Models of ADHD?
S Clare Stanford
Alternatives to Laboratory Animals : ATLA
|
August 12, 2020
Some Reasons Why Preclinical Studies of Psychiatric Disorders Fail to Translate: What Can Be Rescued from the Misunderstanding and Misuse of Animal 'Models'?
S Clare Stanford
British Journal of Pharmacology
|
February 2, 2022
New developments in the prospects for GLP-1 therapy
Stefan Trapp, S Clare Stanford
Page
of 6